Fatal Stroke in a Child with Severe Iron Deficiency Anemia and Multiple Hereditary Risk Factors for Thrombosis

Abstract

Get full access to this article

View all access options for this article.

References

Manco-Johnson MJ , Nuss R . Thrombophilia in the infant and child. Adv Pediatr. 2001;48:363-384.

Robetorye RS , Rodgers GM . Update on selected inherited venous thrombotic disorders. Am J Hematol. 2001;68:256-268.

Chan AKC , deVeber G . Prothrombotic disorders and ischemic stroke in children. Semin Pediatr Neurol. 2000;7(4):301-308.

Ahsen NV , et al. Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A) and MTHFR (C677T) by real time fluorescence PCR with light cycles. Clin Chem. 1999;45:694-696.

Hull RD , Pineo GF . Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendations. Med Clin North Am. 1998;82(3):477-493.

Eeg-Olofsson O , Ringheim Y . Stroke in children. Clinical characteristics and prognosis. Acta Paediatr Scand. 1983;72:391-395.

Broderick J , Talbot T , et al. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.

Virchow R . Phlogose und Thrombose im Gefasssystem. 1856.

Rees DC , Cox M , Clegg JB . World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.

10.

Koster T , Rosendaal FR , et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503-1506.

11.

Rosendaal FR , Koster T , et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504-1508.

12.

Segel GB , Francis CW . Anticoagulant proteins in childhood venous and arterial thrombosis: a review. Blood Cells Mol Dis. 2000;26(5):540-560.

13.

Ganesan V , Kelsey H , et al. Activated protein C resistance in childhood stroke [letter]. Lancet. 1996;347:260.

14.

Nowak-Gottl U , Strater R , et al. , for the Childhood Stroke Study Group. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in children. Blood. 1999;94(11):3678-3682.

15.

Heller C , Becker S , et al. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr. 1999;158(Supplement 3):S117-S121.

16.

Poort SR , Rosendaal FR , et al. A common genetic variant in the 3’ untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.

17.

Margaglione M , Branacaccio V , et al. Increased risk for venous thrombosis in carriers of the prothrombin G to A 20210 gene variant. Ann Intern Med. 1998;129:89-93.

18.

De Stefano V , Chiusolo P , et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998:3562-3565.

19.

Den Heijer M , Koster T , Blom HJ , et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759-762.

20.

Van Beynum IM , Smeitink JAM , et al. Hyperhomocysteinemia A risk factor for ischemic stroke in children. Circulation. 1999;99:2070-2072.

21.

Nachman RL , Silverstein R . Hypercoagulable states. Ann Intern Med. 1993;119:819-827.

22.

Hartfield DS , Lowry NJ , et al. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol. 1997;16:50-53.

23.

Ready WK , Lowry NJ . Anemia causing cerebral infarction in a child. Can Med Assoc J. 1989;140:303-304.

24.

Rosendaal FR . Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167-1173.

25.

Ridker PM , Hennekens CH , et al. Interrelation of Hyperhomocysteinemia, Factor V Leiden, and the risk of future venous thromboembolism. Circulation. 1997;95:1777-1782.

26.

Mandel H , Brenner B , et al. Coexistence of hereditary Homocystinuria and Factor V Leiden-effect on thrombosis. N Engl J Med. 1996;334:763-768.

27.

Green D . Genetic hypercoagulability: screening should be an informed choice. Blood. 2001;98(1):20.

28.

Mannucci PM . Genetic hypercoagulability: prevention suggests testing family members. Blood. 2001;98(1):21-22.

29.

Vandenbroucke JP , Koster T , et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994;344:1453-1457.

30.

Bonduel M , Sciuccati G , et al. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol. 1999;56:967-971.